Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions
Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte antigens (HLA) is frequent and the main cause o...
Saved in:
| Main Authors: | Omer Devecioğlu, Ayşegül Unüvar, Sema Anak, Ilmay Bilge, Haluk Ander, Orhan Ziylan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hacettepe University Institute of Child Health
2003-01-01
|
| Series: | The Turkish Journal of Pediatrics |
| Online Access: | https://turkjpediatr.org/article/view/2858 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hemorrhagic cholecystitis afflicted with glanzmann thrombasthenia patient
by: May AlMoshary
Published: (2024-11-01) -
Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann’s Thrombasthenia Variant
by: Nigel P. Murray, et al.
Published: (2014-01-01) -
Oral invasive procedures in Glanzmann thrombasthenia: a retrospective observational study
by: Maxime Delarue, et al.
Published: (2024-11-01) -
Glanzmann’s Thrombasthenia: How Listening to the Patient Is Sometimes the Simple Key to Good Medicine!
by: Thejus T. Jayakrishnan, et al.
Published: (2020-01-01) -
Deep Vein Thrombosis, Raynaud's Phenomenon, and Prinzmetal Angina in a Patient with Glanzmann Thrombasthenia
by: Alan Nurden, et al.
Published: (2012-01-01)